Related Experiment Video

Updated: Jun 8, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Chemotherapy for low-grade gliomas: when? how? how long?

Michael Weller

    Neuro-Oncology
    |September 24, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

    The Lancet. Oncology·2018

    Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.

    Neuro-oncology·2018

    A tissue-based draft map of the murine MHC class I immunopeptidome.

    Scientific data·2018

    DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

    Neuro-oncology·2018

    Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.

    European journal of cancer (Oxford, England : 1990)·2018

    Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

    Cancer treatment reviews·2018

    How 'Sturgeon' guides the surgeon in pediatric neuro-oncology.

    Neuro-oncology·2026

    CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

    Neuro-oncology·2026

    Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma.

    Neuro-oncology·2026

    Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

    Neuro-oncology·2026

    Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.

    Neuro-oncology·2026

    Phase 2 test of QBS72S for breast cancer leptomeningeal disease.

    Neuro-oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us